Browse 1,572 kidney cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Many kidney cancers are now found by chance, on a scan done for another reason, often while they are still small and curable with surgery. About 9 in 10 are renal cell carcinoma. For advanced kidney cancer, combinations of immunotherapy and targeted drugs have transformed outcomes over the past decade. Trials are testing what comes next when these combinations stop working, and whether extra treatment after surgery can keep the cancer from returning.
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
for
Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06066424
Phase 1, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
for
Solid Tumor, Adult, Colorectal Cancer, NSCLC,
Location: New York NY, Jacksonville FL, Tampa FL, Columbus OH,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06051695
Phase 1, Phase 2, Recruiting
Active & Responsive
Multisite Implementation of COMPRENDO
for
Pediatric Cancer
Location: Boston MA, Birmingham AL, San Diego CA,
Sponsor: University of California, San Diego
Sex: All
Age: 18+
Code: NCT06055296
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Biomarkers to Detect Endocrine Therapy Resistance
for
Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18+
Code: NCT06067503
Phase 2, Recruiting
Active & Responsive
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
Effect of Meal Timing During Adjuvant Treatment for Cancer
for
Cancer
Location: Los Angeles CA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT07524218
Recruiting
Active & Responsive
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors